Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
44.7M
-
Shares change
-
+630K
-
Total reported value, excl. options
-
$134M
-
Value change
-
+$1.58M
-
Number of buys
-
41
-
Number of sells
-
-39
-
Price
-
$3.00
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q3 2015
103 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2015.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.7M shares
of 123M outstanding shares and own 36.31% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (7.34M shares), Consonance Capital Management LP (5.8M shares), FEDERATED INVESTORS INC /PA/ (4.58M shares), Broadfin Capital, LLC (4.18M shares), VANGUARD GROUP INC (2.53M shares), Point72 Asset Management, L.P. (2.21M shares), FRANKLIN RESOURCES INC (2.13M shares), BlackRock Fund Advisors (1.96M shares), SPHERA FUNDS MANAGEMENT LTD. (1.1M shares), and BlackRock Institutional Trust Company, N.A. (1.08M shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.